Raf-kinasen

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

rapidly growing fibrosarcoma kinase

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Raf is an acronym for "Rapidly growing fibrosarcoma". Raf proteins are found in all mammalian tissues and belong to the serine/threonine protein kinases. B-Raf has been identified as a potent oncogene. There is much evidence that the mutation in the B-RAF gene occurs early in the development of a tumour. B-RAF mutations play an important role in the genesis of malignant melanoma.

General informationThis section has been translated automatically.

  • Raf kinases include the following isoforms:
    • A-Raf
    • B-Raf
    • C-Raf (or Raf-1).
  • Raf kinases play an important role in the MAP kinase signalling pathway (MAP = acronym for "mitogen-activated protein"). The MAP kinase signalling pathway is a central cellular signalling pathway that plays a crucial role in regulating cell proliferation, differentiation and survival. RAF kinases play a key role in tumorigenesis. They are probably regulated by the small G protein Ras (acronym for "rat sarcoma"), which must be present in its active, GTP-bound form.

Note(s)This section has been translated automatically.

The development of specific irreversible kinase inhibitors (which could play a role in the therapy of metastasized malignant melanoma ) has now been successful and represents an attractive approach to tumor suppression (see sorafenib below).

Authors

Last updated on: 29.10.2020